Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung Cancer
Roy M. Bremnes, Lill‐Tove Busund, Thomas L. Kilvær, et al.
Journal of Thoracic Oncology (2016) Vol. 11, Iss. 6, pp. 789-800
Open Access | Times Cited: 420

Showing 1-25 of 420 citing articles:

Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
Sisi Wang, Wei Liu, Dalam Ly, et al.
Cellular and Molecular Immunology (2018) Vol. 16, Iss. 1, pp. 6-18
Open Access | Times Cited: 429
Regenerative lineages and immune-mediated pruning in lung cancer metastasis
Ashley M. Laughney, Jing Hu, Nathaniel R. Campbell, et al.
Nature Medicine (2020) Vol. 26, Iss. 2, pp. 259-269
Open Access | Times Cited: 370
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer
Xinyan Liu, Shucai Wu, Yonghui Yang, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 95, pp. 55-61
Closed Access | Times Cited: 306
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, et al.
Cellular Immunology (2018) Vol. 343, pp. 103753-103753
Closed Access | Times Cited: 200
Exosome-Based Detection of EGFR T790M in Plasma from Non–Small Cell Lung Cancer Patients
Elena Castellanos-Rizaldos, Dominik G. Grimm, Vasisht Tadigotla, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 12, pp. 2944-2950
Open Access | Times Cited: 184
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
Shuguang Zuo, Min Wei, Shiqun Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 161
Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy inEGFR/ALKwild-type advanced non-small cell lung cancer
Xiaoxiao Peng, Ruoying Yu, Xue Wu, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000376-e000376
Open Access | Times Cited: 145
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
Jordi Remón, Francesco Passiglia, Myung‐Ju Ahn, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 6, pp. 914-947
Open Access | Times Cited: 140
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications
Karim Rihawi, Angela Dalia Ricci, Alessandro Rizzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3805-3805
Open Access | Times Cited: 132
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
Clelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6489-6489
Open Access | Times Cited: 83
Diversity of immune checkpoints in cancer immunotherapy
Zhangyan Guo, Rui Zhang, Angang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
Emeka K. Enwere, Elizabeth Kornaga, Michelle L. Dean, et al.
Modern Pathology (2017) Vol. 30, Iss. 4, pp. 577-586
Open Access | Times Cited: 164
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
Hawazin Faruki, Gregory M. Mayhew, Jonathan S. Serody, et al.
Journal of Thoracic Oncology (2017) Vol. 12, Iss. 6, pp. 943-953
Open Access | Times Cited: 142
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Mehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, et al.
Neoplasia (2019) Vol. 21, Iss. 3, pp. 282-293
Open Access | Times Cited: 134
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery
Egesta Lopci, Luca Toschi, Fabio Grizzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2016) Vol. 43, Iss. 11, pp. 1954-1961
Closed Access | Times Cited: 132
Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer
Yoonjin Kwak, Jiwon Koh, Duck-Woo Kim, et al.
Oncotarget (2016) Vol. 7, Iss. 49, pp. 81778-81790
Open Access | Times Cited: 114
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
Cinzia Solinas, Luisa Carbognin, Pushpamali De Silva, et al.
The Breast (2017) Vol. 35, pp. 142-150
Closed Access | Times Cited: 104
Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non–Small Cell Lung Cancer
Nicholas M. Mark, Julia Kargl, Stephanie Busch, et al.
American Journal of Respiratory and Critical Care Medicine (2017) Vol. 197, Iss. 3, pp. 325-336
Open Access | Times Cited: 99
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC
Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
Lung Cancer (2018) Vol. 127, pp. 153-163
Closed Access | Times Cited: 98
Exosomes from heat‐stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL‐6
Danfeng Guo, Yinghu Chen, Shoujie Wang, et al.
Immunology (2017) Vol. 154, Iss. 1, pp. 132-143
Open Access | Times Cited: 94
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
Alberto Pavan, Ilaria Attili, Giulia Pasello, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 83
Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment
Xiaoliang Zhao, Bhaskar Kallakury, Joeffrey Chahine, et al.
Journal of Thoracic Oncology (2019) Vol. 14, Iss. 5, pp. 914-923
Open Access | Times Cited: 81
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
Mehrdad Rakaee, Thomas K. Kilvaer, Simin Jamaly, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 10, pp. 1680-1689
Open Access | Times Cited: 76
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations
Masashi Fujita, Takafumi N. Yamaguchi, Takanori Hasegawa, et al.
EBioMedicine (2020) Vol. 53, pp. 102659-102659
Open Access | Times Cited: 71
The Role of the ECM in Lung Cancer Dormancy and Outgrowth
Amelia L. Parker, Thomas R. Cox
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top